OCT 11 - 12 2017 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Cancer Research & Oncology 2017
10 20 1151

The 5th Annual LabRoots Cancer Research & Oncology Virtual Conference will take place in October 2017. LabRoots invites research professionals, scientists, and clinicians to this premier online conference, making it easier and more cost-effective to learn about recent advances in cancer research. The virtual conference is free to attendees, encouraging worldwide collaboration and connections between colleagues and field experts.

Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Within the last year, we have seen progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.

Cancer Research & Oncology 2017 will focus on advancements in prevention, diagnosis and treatment of different cancer types. The world’s thought leaders in cancer research will present their latest discoveries in cancer mechanics and detection as well as clinical aspects such as targeted therapies and novel treatments, all in an international venue conducive to networking.

Attendees can earn free CME and CE Credits.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRcancer to follow the conversation
 
 


Show Resources
Agenda
All times are Pacific Time
Speakers

Sponsored By

For information on becoming a sponsor or exhibitor, please click here.


Committee

To download the Program Committee brochure here.


  • David Albala, MD

    Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...

    See more See less
  • Sharon Geaghan, MD

    Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

    See more See less
  • R. Claudio Aguilar, Ph.D.

    Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

    See more See less
  • Antonio Baines, PhD

    Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

    See more See less
  • Josip Blonder, MD

    Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

    See more See less
  • Peter Blume-Jensen, MD, PhD

    Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

    See more See less
  • Fred Russell Kramer, PhD

    Fred Russell Kramer is Professor of Microbiology and Molecular Genetics at the New Jersey Medical School, and has been a Principal Investigator at the Public Health Research Institute for the past 25 years. He graduated from the University of Michigan in 1964 and received his ...

    See more See less
  • Martin Latterich, PhD

    The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

    See more See less
  • Ariel Louwrier PhD

    Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

    See more See less
  • Judd Moul, MD, FACS

    Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

    See more See less
  • Eric Klein, MD

    Eric A. Klein, MD, is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic. His clinical interests are cancers of the prostate, testis and kidney. For several years, including the current edition, Dr ...

    See more See less
  • Thomas Polascik, MD

    Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency ...

    See more See less
  • Rajan Gupta, MD

    Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...

    See more See less
Help

General LabRoots Questions

For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
Contact us

Virtual Events and Webinars

Supported Configurations

  • Operating System Internet Explorer Firefox Chrome Safari
    Vista IE8+ FF10+ Chrome15+
    Windows 7 IE8+ FF10+ Chrome15+
    Windows 8 IE10 FF10+ Chrome15+
    Mac OS X   FF10+ Chrome15+ Safari5.1+
  • Cookie settings: session cookies enabled
  • Browser configuration must have JavaScript enabled
  • Adobe Flash player 10.2 or later

To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

Internet Connection

  • A minimum of 100Kbps is recommended for audio-only events
  • A minimum of 300Kbps is recommended for speaker on-video events

Computer Equipment

  • Screen Resolution: Minimum 1024x768
  • Video Card: 65,000 colors minimum
  • Sound card and speakers (or headphones) for hearing webcast in full format
  • Audio Card: 16-bit minimum
  • RAM: 512MB of free RAM

Firewall Protocol

  • HTTP on port 80 or HTTPS on port 443
  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

Work-At-Home Attendees

  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

For A Seamless Experience

When using a mobile device, FREE Mobile Apps are available:

- For viewing Webinars:

- For viewing Virtual Events

Attendee Guide

  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

Virtual Event and Webinar Support:

Continuing Education (CME/CE) Support

Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds